SUPN logo

Supernus Pharmaceuticals (SUPN) Operating expenses

annual operating expenses:

$508.36M-$1.98M(-0.39%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SUPN annual total operating expenses is $508.36 million, with the most recent change of -$1.98 million (-0.39%) on December 31, 2024.
  • During the last 3 years, SUPN annual operating expenses has risen by +$83.14 million (+19.55%).
  • SUPN annual operating expenses is now -4.87% below its all-time high of $534.40 million, reached on December 31, 2022.

Performance

SUPN Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

quarterly operating expenses:

$136.66M+$10.36M(+8.20%)
March 31, 2025

Summary

  • As of today (May 29, 2025), SUPN quarterly total operating expenses is $136.66 million, with the most recent change of +$10.36 million (+8.20%) on March 31, 2025.
  • Over the past year, SUPN quarterly operating expenses has increased by +$5.07 million (+3.86%).
  • SUPN quarterly operating expenses is now -10.40% below its all-time high of $152.51 million, reached on September 30, 2022.

Performance

SUPN quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

SUPN Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.4%+3.9%
3 y3 years+19.6%+3.6%
5 y5 years+123.4%+121.1%

SUPN Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-4.9%+19.6%-10.4%+21.5%
5 y5-year-4.9%+123.4%-10.4%+121.1%
alltimeall time-4.9%+2083.6%-10.4%+1590.0%

SUPN Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$136.66M(+8.2%)
Dec 2024
$508.36M(-0.4%)
$126.30M(+6.8%)
Sep 2024
-
$118.28M(-10.5%)
Jun 2024
-
$132.19M(+0.5%)
Mar 2024
-
$131.58M(+4.7%)
Dec 2023
$510.34M(-4.5%)
$125.70M(-0.7%)
Sep 2023
-
$126.60M(-3.6%)
Jun 2023
-
$131.27M(+3.5%)
Mar 2023
-
$126.78M(+12.7%)
Dec 2022
$534.40M(+25.7%)
$112.44M(-26.3%)
Sep 2022
-
$152.51M(+10.9%)
Jun 2022
-
$137.50M(+4.2%)
Mar 2022
-
$131.94M(-2.1%)
Dec 2021
$425.21M(+45.5%)
$134.84M(+38.0%)
Sep 2021
-
$97.69M(+7.4%)
Jun 2021
-
$90.94M(-10.6%)
Mar 2021
-
$101.74M(+26.7%)
Dec 2020
$292.34M(+28.5%)
$80.33M(+3.8%)
Sep 2020
-
$77.41M(+6.3%)
Jun 2020
-
$72.80M(+17.8%)
Mar 2020
-
$61.81M(+11.3%)
Dec 2019
$227.52M(-8.7%)
$55.52M(-3.6%)
Sep 2019
-
$57.59M(-0.8%)
Jun 2019
-
$58.05M(+3.0%)
Mar 2019
-
$56.36M(-21.6%)
Dec 2018
$249.10M(+32.9%)
$71.89M(+17.3%)
Sep 2018
-
$61.31M(+2.0%)
Jun 2018
-
$60.13M(+7.9%)
Mar 2018
-
$55.76M(+11.7%)
Dec 2017
$187.48M
$49.94M(-7.2%)
DateAnnualQuarterly
Sep 2017
-
$53.80M(+17.2%)
Jun 2017
-
$45.90M(+21.3%)
Mar 2017
-
$37.84M(-10.6%)
Dec 2016
$148.80M(+25.9%)
$42.31M(+26.1%)
Sep 2016
-
$33.54M(-9.9%)
Jun 2016
-
$37.23M(+4.2%)
Mar 2016
-
$35.72M(+8.2%)
Dec 2015
$118.20M(+28.2%)
$33.01M(+3.1%)
Sep 2015
-
$32.03M(+6.5%)
Jun 2015
-
$30.07M(+30.3%)
Mar 2015
-
$23.09M(-3.1%)
Dec 2014
$92.20M(+26.6%)
$23.83M(+7.8%)
Sep 2014
-
$22.10M(-8.9%)
Jun 2014
-
$24.26M(+10.2%)
Mar 2014
-
$22.01M(+6.7%)
Dec 2013
$72.83M(+66.9%)
$20.63M(+12.1%)
Sep 2013
-
$18.40M(+16.8%)
Jun 2013
-
$15.76M(-12.7%)
Mar 2013
-
$18.05M(+30.5%)
Dec 2012
$43.65M(+13.2%)
$13.83M(+11.7%)
Sep 2012
-
$12.38M(+32.4%)
Jun 2012
-
$9.35M(+15.6%)
Mar 2012
-
$8.09M(-21.4%)
Dec 2011
$38.55M(-4.2%)
$10.29M(+3.6%)
Sep 2011
-
$9.93M(+8.5%)
Jun 2011
-
$9.15M(-0.6%)
Mar 2011
-
$9.20M(-14.5%)
Dec 2010
$40.23M(+18.6%)
$10.76M(+25.1%)
Dec 2009
$33.91M(-2.4%)
$8.60M
Dec 2008
$34.75M(+49.3%)
-
Dec 2007
$23.28M
-

FAQ

  • What is Supernus Pharmaceuticals annual total operating expenses?
  • What is the all time high annual operating expenses for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual operating expenses year-on-year change?
  • What is Supernus Pharmaceuticals quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals quarterly operating expenses year-on-year change?

What is Supernus Pharmaceuticals annual total operating expenses?

The current annual operating expenses of SUPN is $508.36M

What is the all time high annual operating expenses for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual total operating expenses is $534.40M

What is Supernus Pharmaceuticals annual operating expenses year-on-year change?

Over the past year, SUPN annual total operating expenses has changed by -$1.98M (-0.39%)

What is Supernus Pharmaceuticals quarterly total operating expenses?

The current quarterly operating expenses of SUPN is $136.66M

What is the all time high quarterly operating expenses for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly total operating expenses is $152.51M

What is Supernus Pharmaceuticals quarterly operating expenses year-on-year change?

Over the past year, SUPN quarterly total operating expenses has changed by +$5.07M (+3.86%)
On this page